Cargando…

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions

PAX5 encodes a master regulator of B-cell development. It fuses to other genes associated with acute lymphoblastoid leukemia (ALL). These fusion products are potent dominant-negative (DN) inhibitors of wild-type PAX5 resulting in a blockade of B-cell differentiation. Here, we show that multimerizati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamata, Norihiko, Pennella, Mario A., Woo, Jennifer L., Berk, Arnold J., Koeffler, H. Phillip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197879/ https://www.ncbi.nlm.nih.gov/pubmed/21765475 http://dx.doi.org/10.1038/onc.2011.291

Ejemplares similares

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma
por: Dehner, Carina A., et al.
Publicado: (2021)

Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
por: Zhang, Ming, et al.
Publicado: (2022)

Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment
por: Zheng, Xiaomin, et al.
Publicado: (2009)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity
por: Weng, Stephanie, et al.
Publicado: (2016)

Using Bioinformatic Approaches to Identify Pathways Targeted by Human Leukemogens
por: Thomas, Reuben, et al.
Publicado: (2012)

Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice
por: Usenko, Tatiana, et al.
Publicado: (2014)

Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
por: Mendes, Adélia, et al.
Publicado: (2020)

Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016)

Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023)

Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanism
por: Gole, Boris, et al.
Publicado: (2015)

PAX5 fusion genes in acute lymphoblastic leukemia: A literature review
por: Fouad, Fatma Mohamed, et al.
Publicado: (2023)

Pax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1
por: Yu, Jiyeon, et al.
Publicado: (2021)

Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
por: Azran, Inbal, et al.
Publicado: (2004)

Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen
Publicado: (1987)

Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways
por: Gow, Chien-Hung, et al.
Publicado: (2014)

Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9
por: Huang, Yun, et al.
Publicado: (2020)

Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue.
por: Yoon, Byung-Il, et al.
Publicado: (2003)

PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma
por: Hanna, J A, et al.
Publicado: (2016)

Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters
por: Hsu, Emily, et al.
Publicado: (2018)

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice
Publicado: (1980)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)

The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression
por: Fleischmann, Katrin K., et al.
Publicado: (2016)

Run-on mutation in the PAX6 gene and chorioretinal degeneration in autosomal dominant aniridia
por: Aggarwal, Shagun, et al.
Publicado: (2011)

Modeling HTLV-lymphomagenesis: immune activation induces immortalization and leukemogenicity of HTLV-1 LTR-Tax transgenic CD4(+)T-cells
por: Swaims, Alison Y, et al.
Publicado: (2009)

Genetic differences between Asian and Caucasian chronic lymphocytic leukemia
por: KAWAMATA, NORIHIKO, et al.
Publicado: (2013)

Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2012)

Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia
por: Chen, Chiqi, et al.
Publicado: (2021)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
por: Fortin, Jerome, et al.
Publicado: (2023)

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling
por: Zhao, Yuming, et al.
Publicado: (2023)

The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
por: Kugler, Eitan, et al.
Publicado: (2023)

Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements
por: Mendes, Adélia, et al.
Publicado: (2020)

A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia
por: Zhang, Hao, et al.
Publicado: (2022)

PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation
por: Cresson, Charlotte, et al.
Publicado: (2018)

Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations
por: Hart, Matthew R., et al.
Publicado: (2018)

Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia
por: Brémond-Gignac, Dominique, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gnmaqtoa07hck02di577903i70